Reena is delighted to announce the appointment of Charles Chee as its new Chair of the Board.
Charles Chee – Incoming Chair

Replacing Jeff Bernstein as the Chair of our Board is Charles Chee who is a valued member of the Reena community. In 2015, Charles became a member of the Reena Board of Directors and shortly after served on the Continuous Quality Improvement committee.
Charles is a regulatory compliance executive with over 35 years of experience in the pharmaceutical, biotechnology, and life science industries. His portfolio includes drug development, manufacturing and business development.
In 2015, Charles and a small group of colleagues founded Qing Bile Therapeutics Inc., a research and development pharmaceutical company engaged in finding cures for liver diseases. Over the past 10 years, Charles has provided consulting services for several companies on issues relating to regulatory compliance, drug development and manufacturing operations.
Serving the community has been an integral part of Charles’s life. Within his professional sphere, Charles serves as a board member at the Pharmaceutical Science Group (PSG), a not-for-profit industry organization focused on the development and training of pharmaceutical professionals.
Charles holds a Bachelor’s degree in Honours Biology from the University of Waterloo; a certificate in Business Administration from Ryerson Polytechnical Institute, and a Graduate Diploma in Christian Studies from Tyndale University College and Seminary.
We are confident that Charles’s professional experience and commitment to Reena will be an asset as he embarks on his new role as our Board Chair. One of Charles’s responsibilities will be overseeing the implementation of Beyond 20/20, Reena’s new 2020-2025 strategic plan.
We wish him much success in the coming years.
We wish him much success in the coming years.
|
||
|